| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445365 | European Journal of Cancer | 2013 | 9 Pages |
Abstract
RAI3 is a putative prognostic marker that identifies a small subset of CC patients with high recurrence risk. This study demonstrates the potential value of modern proteomic technology in clinically relevant applications.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alexandre Zougman, Gordon G. Hutchins, David A. Cairns, Eldo Verghese, Sarah L. Perry, David G. Jayne, Peter J. Selby, Rosamonde E. Banks,